Zobrazeno 1 - 10
of 245
pro vyhledávání: '"Scicinski, Jan"'
Autor:
Raghunand, Natarajan, Scicinski, Jan, Guntle, Gerald P., Jagadish, Bhumasamudram, Mash, Eugene A., Bruckheimer, Elizabeth, Oronsky, Bryan, Korn, Ronald L.
RRx-001 is an anticancer agent that subjects cancer cells to reactive oxygen/nitrogen species (ROS/RNS) and acts as an epigenetic modifier. We have used a thiol-bearing MRI contrast agent, Gd-LC7-SH, to investigate the pharmacodynamics of RRx-001 in
Externí odkaz:
http://hdl.handle.net/10150/627064
http://arizona.openrepository.com/arizona/handle/10150/627064
http://arizona.openrepository.com/arizona/handle/10150/627064
Autor:
Oronsky, Bryan, Carter, Corey A., Reid, Tony R., Scicinski, Jan, Oronsky, Arnold, Lybeck, Michelle, Caroen, Scott, Stirn, Meaghan, Oronsky, Neil, Langecker, Peter
Publikováno v:
In Neoplasia September 2015 17(9):716-722
Autor:
Reid, Tony, Oronsky, Bryan, Scicinski, Jan, Scribner, Curt L, Knox, Susan J, Ning, Shoucheng, Peehl, Donna M, Korn, Ron, Stirn, Meaghan, Carter, Corey A, Oronsky, Arnold, Taylor, Michael J, Fitch, William L, Cabrales, Pedro, Kim, Michelle M, Burris, Howard A, 3rd, Lao, Christopher D, Abrouk, Nacer E D, Fanger, Gary R, Infante, Jeffrey R
Publikováno v:
In The Lancet Oncology September 2015 16(9):1133-1142
Autor:
Eichenbaum, Gary *, Hsu, C.-P., Subrahmanyam, Vangala, Chen, Jing, Scicinski, Jan, Galemmo, Robert A., Jr., Tuman, Robert W., Johnson, Dana L.
Publikováno v:
In Journal of Pharmaceutical Sciences July 2012 101(7):2545-2556
Autor:
Scicinski, Jan, Kashfi, Khosrow
Publikováno v:
In Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders 2019:123-158
Autor:
Oronsky, Bryan1 boronsky@epicentrx.com, Scicinski, Jan1 jscicinski@epicentrx.com, Kim, Michelle M.2 michekim@med.umich.edu, Cabrales, Pedro3 pcabrales@ucsd.edu, Salacz, Michael E.4 msalacz@kumc.edu, Carter, Corey A.5 corey.carter33@gmail.com, Oronsky, Neil6 nco@cflsdata.com, Lybeck, Harry7 harrylybeck@gmail.com, Lybeck, Michelle1 lybeck.michelle@gmail.com, Larson, Christopher8 chris.larson.mail@gmail.com, Reid, Tony R.8 tonyreid@ucsd.edu, Oronsky, Arnold9 AOronsky@interwest.com
Publikováno v:
Biomolecules (2218-273X). Sep2016, Vol. 6 Issue 3, p32. 13p.
Autor:
Oronsky, Bryan1 Boronsky@epicentrx.com, Scicinski, Jan1, Cabrales, Pedro2, Minchinton, Andrew3
Publikováno v:
Clinical Epigenetics. 5/11/2016, Vol. 8, p1-8. 8p.
Autor:
Scicinski, Jan *, Oronsky, Bryan *, Caroen, Scott *, Cabrales, Pedro, Summers, Thomas A., Reid, Tony R., Kim, Michelle M., Trepel, Jane B., Lee, Min-Jung, Abrouk, Nacer D. **, Day, Regina M., Jha, Saheli *, Oronsky, Arnold, Carter, Corey A.
Publikováno v:
In Nitric Oxide (Donor/Induced) in Chemosensitization 2018:35-56
Autor:
Carter, Corey A., Oronsky, Bryan T., Roswarski, Joseph, Oronsky, Arnold L., Oronsky, Neil, Scicinski, Jan, Lybeck, Harry, Kim, Michelle M., Lybeck, Michelle, Reid, Tony R.
Checkpoint inhibitors, monoclonal antibodies that inhibit PD-1 or CTLA-4, have revolutionized the treatment of multiple cancers. Despite the enthusiasm for the clinical successes of checkpoint inhibitors, and immunotherapy, in general, only a minorit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1593::ae2a5e703a0a3782d4dc013481080f44
http://hdl.handle.net/10138/228981
http://hdl.handle.net/10138/228981